tradingkey.logo

electroCore, Inc.

ECOR
5.450USD
0.0000.00%
交易中 美東報價延遲15分鐘
41.61M總市值
虧損本益比TTM

electroCore, Inc.

5.450
0.0000.00%

關於 electroCore, Inc. 公司

electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company focused on improving health through its non-invasive vagus nerve stimulation (nVNS) technology platform and related product offerings. The Company’s portfolio also includes Quell, a wearable, app and cloud-enabled neuromodulation platform that is indicated for the treatment of fibromyalgia symptoms and lower-extremity chronic pain. Its product categories include handheld, personal use medical devices for the management and treatment of certain medical conditions such as primary headaches, and handheld, personal use consumer products. Its products include gammaCore, Quell Fibromyalgia, Truvaga and TAC-STIM. Its gammaCore Sapphire is a prescription medical device that is used for a variety of primary headache conditions. Truvaga is a personal-use consumer electronics general wellness product that does not require a prescription and is available direct-to-consumer from electroCore at www.truvaga.com.

electroCore, Inc.簡介

公司代碼ECOR
公司名稱electroCore, Inc.
上市日期Jun 22, 2018
CEOGoldberger (Daniel S)
員工數量73
證券類型Ordinary Share
年結日Jun 22
公司地址200 Forge Way
城市ROCKAWAY
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編07866
電話19732900097
網址https://www.electrocore.com/
公司代碼ECOR
上市日期Jun 22, 2018
CEOGoldberger (Daniel S)

electroCore, Inc.公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Daniel S. (Dan) Goldberger
Mr. Daniel S. (Dan) Goldberger
Chief Executive Officer, Director
Chief Executive Officer, Director
232.27K
+46375.00%
Mr. Thomas M. (Tom) Patton, J.D.
Mr. Thomas M. (Tom) Patton, J.D.
Independent Director
Independent Director
102.78K
+19011.00%
Mr. John P. Gandolfo
Mr. John P. Gandolfo
Independent Director
Independent Director
88.10K
+19011.00%
Ms. Patricia Wilber
Ms. Patricia Wilber
Independent Director
Independent Director
72.33K
+19011.00%
Ms. Elena Bonfiglioli
Ms. Elena Bonfiglioli
Director
Director
30.55K
+30549.00%
Dr. Thomas J. Errico, M.D.
Dr. Thomas J. Errico, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Julie A. Goldstein
Ms. Julie A. Goldstein
Independent Director
Independent Director
--
--
Mr. Joshua S. Lev
Mr. Joshua S. Lev
Chief Financial Officer
Chief Financial Officer
--
--
Mr. James C. Theofilos
Mr. James C. Theofilos
Director
Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Daniel S. (Dan) Goldberger
Mr. Daniel S. (Dan) Goldberger
Chief Executive Officer, Director
Chief Executive Officer, Director
232.27K
+46375.00%
Mr. Thomas M. (Tom) Patton, J.D.
Mr. Thomas M. (Tom) Patton, J.D.
Independent Director
Independent Director
102.78K
+19011.00%
Mr. John P. Gandolfo
Mr. John P. Gandolfo
Independent Director
Independent Director
88.10K
+19011.00%
Ms. Patricia Wilber
Ms. Patricia Wilber
Independent Director
Independent Director
72.33K
+19011.00%
Ms. Elena Bonfiglioli
Ms. Elena Bonfiglioli
Director
Director
30.55K
+30549.00%
Dr. Thomas J. Errico, M.D.
Dr. Thomas J. Errico, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--

收入明細

單位: USD更新時間: 1月6日 週二
單位: USD更新時間: 1月6日 週二
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
業務USD
名稱
營收
佔比
Health and Wellness Products
6.81M
78.37%
Prescription Devices
1.88M
21.63%
地區USD
名稱
營收
佔比
United States
8.22M
94.63%
United Kingdom
402.00K
4.63%
Other
48.00K
0.55%
Japan
17.00K
0.20%
業務
地區
業務USD
名稱
營收
佔比
Health and Wellness Products
6.81M
78.37%
Prescription Devices
1.88M
21.63%

股東統計

更新時間: 2月6日 週五
更新時間: 2月6日 週五
持股股東
股東類型
持股股東
持股股東
佔比
Zhang (Tianyi)
9.19%
Theofilos (Charles Steve)
5.56%
Hilve Holdings Ltd
5.40%
Errico (Thomas J.)
3.83%
The Vanguard Group, Inc.
3.04%
其他
72.98%
持股股東
持股股東
佔比
Zhang (Tianyi)
9.19%
Theofilos (Charles Steve)
5.56%
Hilve Holdings Ltd
5.40%
Errico (Thomas J.)
3.83%
The Vanguard Group, Inc.
3.04%
其他
72.98%
股東類型
持股股東
佔比
Individual Investor
27.86%
Corporation
8.76%
Investment Advisor
7.46%
Investment Advisor/Hedge Fund
1.59%
Hedge Fund
1.57%
Research Firm
0.02%
其他
52.74%

機構持股

更新時間: 12月8日 週一
更新時間: 12月8日 週一
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
76
832.27K
10.41%
-518.60K
2025Q3
75
727.72K
17.61%
-444.98K
2025Q2
70
1.17M
19.50%
-199.13K
2025Q1
65
1.37M
13.77%
+380.78K
2024Q4
69
936.59K
18.00%
-138.83K
2024Q3
59
1.06M
17.69%
+20.62K
2024Q2
62
1.04M
19.14%
+51.56K
2024Q1
68
992.08K
19.07%
-152.78K
2023Q4
66
961.96K
18.72%
+22.04K
2023Q3
73
937.71K
13.66%
+316.94K
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Zhang (Tianyi)
734.64K
9.19%
+734.64K
--
May 15, 2025
Theofilos (Charles Steve)
444.53K
5.56%
--
--
Jul 04, 2025
Hilve Holdings Ltd
432.00K
5.4%
+432.00K
--
Aug 15, 2025
Errico (Thomas J.)
306.38K
3.83%
+26.61K
+9.51%
Sep 02, 2025
The Vanguard Group, Inc.
233.47K
2.92%
+1.14K
+0.49%
Sep 30, 2025
Goldberger (Daniel S)
185.90K
2.32%
+1.00K
+0.54%
Dec 02, 2025
Happy Holstein Management, LLC
153.17K
1.92%
--
--
Jul 04, 2025
MAZ Partners, L.P.
115.52K
1.44%
-156.44K
-57.52%
May 13, 2025
Patton (Thomas M)
102.78K
1.29%
+19.01K
+22.69%
Sep 02, 2025
Goldstein (Julie Ann)
101.39K
1.27%
+19.01K
+23.08%
Sep 02, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
佔比0%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
除權除息日
類型
比率
Feb 14, 2023
Merger
15→1
Feb 14, 2023
Merger
15→1
Feb 14, 2023
Merger
15→1
Feb 14, 2023
Merger
15→1
公告日期
除權除息日
類型
比率
Feb 14, 2023
Merger
15→1
Feb 14, 2023
Merger
15→1
Feb 14, 2023
Merger
15→1
Feb 14, 2023
Merger
15→1
KeyAI